ArticleMedical sciences (Basel, Switzerland)2026
Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.
Patricia Diez-Echave, María Jesús Rodríguez-Sojo, Benita Martin-Castaño, Laura Hidalgo-García, Antonio Jesús Ruiz-Malagon, José Alberto Molina-Tijeras, Anaïs Redruello Romero, Margarita Martínez-Zaldívar, Emilio Mota, Fernando Cobo and 17 more
Abstract read
In one paragraphArticle in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
27 authors.
Patricia Diez-EchaveDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0003-4493-3091 María Jesús Rodríguez-SojoDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0002-1693-505X Benita Martin-CastañoInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Laura Hidalgo-GarcíaDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.
Antonio Jesús Ruiz-MalagonDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0003-4323-650X José Alberto Molina-TijerasDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0003-1554-9226 Anaïs Redruello RomeroInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Margarita Martínez-ZaldívarInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Emilio MotaCentro de Salud "Salvador Caballero", Distrito Granada-Metropolitano, 18012 Granada, Spain.ORCID 0000-0002-9980-9947 Fernando CoboInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-9203-9628 Marta Alvarez-EstevezInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Federico GarcíaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0001-7611-781X Concepción Morales-GarcíaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Silvia MerlosInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Paula García-FloresInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Manuel Colmenero-RuizInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0001-5005-1154 María NuñezInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Andrés Ruiz-SanchoServicio de Infecciosas, Hospital Universitario Clínico San Cecilio, 18016 Granada, Spain.
María Elena Rodríguez-CabezasDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0001-9085-8147 Ángel Carazo GallegoInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Emilio Fernandez-VarónDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0001-8253-6252 Javier MartinDepartment of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, CSIC, 18016 Granada, Spain.ORCID 0000-0002-2202-0622 Jorge García-GarcíaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0003-0925-9441 Alba Rodríguez-NogalesDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0003-1927-0628 Julio GálvezDepartment of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.ORCID 0000-0001-6876-3782 Funding
Andalusian Health Service CV20-99908
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Gastrointestinal MicrobiomeMetabolomeAgedFecesFemaleHumansMaleMetabolomicsMiddle AgedProspective StudiesRNA, Ribosomal, 16SSARS-CoV-2Severity of Illness IndexRNA, Ribosomal, 16SbiomarkersCOVID-19 severitymetabolomicmicrobiomeSARS-CoV-2
Identifiers
PMID41718144
PMCPMC12921900
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390